New York Codes, Rules and Regulations
Title 10 - DEPARTMENT OF HEALTH
Chapter II - Administrative Rules and Regulations
Subchapter I - Environmental Health
Part 70 - Regulated Medical Waste
Subpart 70-5 - Approval Of Alternative Treatment Technologies For Use In New York State
Section 70-5.1 - Treatment technology approval
Current through Register Vol. 46, No. 12, March 20, 2024
(a) No alternative regulated medical waste treatment system shall be used in New York State unless the Commissioner of Health has approved the system's technology pursuant to this Subpart. The system manufacturer, as applicant for technology approval, shall:
(b) Whenever mycobacterium species is used as a biological indicator, effective treatment shall be demonstrated by a 6 log 10 reduction in viable cell concentrations; Bacillus atrophaeus or Geobacillus stearothermophilus are used as a biological indicator, effective treatment shall be demonstrated a 4 log 10 reduction in viable spores concentration. No alternative treatment system that fails to attain such reductions or fails to demonstrate that the waste has been treated shall be used to treat regulated medical waste.
(c) The department may require that the system undergo supplemental efficacy testing using organisms or agents other than those identified in subdivision (b) of this section, and may require the manufacturer to demonstrate that the technology meets manufacturer's claims for effective treatment of non-typical bioloads or materials, for example, new and emerging pathogens or pathological waste.